Literature DB >> 22368936

[Atrial fibrillation: epidemiological data from the Cardiology Institute in Abidjan, Côte d'Ivoire].

I Coulibaly1, J B Anzouan-Kacou, Kouao C Konin, S C Kouadio, R Abouo-N'Dori.   

Abstract

UNLABELLED: The purpose of this retrospective study covering a 10-year period was to analyze epidemiological data and associated conditions related to atrial fibrillation (AF) in a cardiology hospital setting in SubSaharan Africa. PATIENTS AND METHODS: A total of 217 charts of patients hospitalized in the Medical Department of the Abidjan Cardiology Institute between August 1995 and August 2005 were reviewed.
RESULTS: During the study, a total of 3,908 patients were admitted to the department, including 217 for AF for a hospital prevalence of 5.5%. There were 113 men (52%) and 104 women (48%) for a sex ratio of 1.08. Overall mean patient age was 58.9 years (range, 18 to 91 years). The difference in the mean age of men and women was not statistically significant: 57.8 versus 60 years respectively. The main symptoms at the time of admission to the hospital were exertional dyspnea (55.7%) and palpitations (22.1%). A total of 136 patients (62.6%) exhibited cardiac insufficiency. Heart disease was diagnosed in 192 patients including hypertensive cardiopathy in 48% and rheumatic valvular heart disease in 28%. The thromboembolic risk was moderate in 47% of patients (CHADS2 score, between 1 and 2) and high in 18.4% (CHADS2 score > or = 3).
CONCLUSION: In our practice, hypertensive and rheumatic valvular heart disease were the main causes of AF that was associated with an alarming thromboembolic risk. These findings indicate that further effort is needed to prevent arterial hypertension and acute rheumatic joint disease.

Entities:  

Mesh:

Year:  2010        PMID: 22368936

Source DB:  PubMed          Journal:  Med Trop (Mars)        ISSN: 0025-682X


  5 in total

1.  Atrial fibrillation among the black population in a Ugandan tertiary hospital.

Authors:  Charles Lugero; Davis Kibirige; James Kayima; Charles Kizza Mondo; Jurgen Freers
Journal:  Int J Gen Med       Date:  2016-06-08

2.  Use of Vitamins K antagonists in non-valvular atrial fibrillation thromboembolic risk prevention in Burkina Faso.

Authors:  Aristide Relwendé Yameogo; Jonas Koudougou Kologo; Germain Mandi; Hervé Poko Kabore; Georges Rosario Christian Millogo; Arthur André Taryetba Seghda; André Koudnoaga Samadoulougou; Patrice Zabsonre
Journal:  Pan Afr Med J       Date:  2016-05-31

Review 3.  Atrial fibrillation in Sub-Saharan Africa: epidemiology, unmet needs, and treatment options.

Authors:  Bruce Sheldon Stambler; Leonard M Ngunga
Journal:  Int J Gen Med       Date:  2015-07-31

4.  Scarcity of atrial fibrillation in a traditional African population: a community-based study.

Authors:  Jacob J E Koopman; David van Bodegom; Rudi G J Westendorp; Johan Wouter Jukema
Journal:  BMC Cardiovasc Disord       Date:  2014-07-18       Impact factor: 2.298

5.  A Systematic Review of the Spectrum of Cardiac Arrhythmias in Sub-Saharan Africa.

Authors:  Matthew F Yuyun; Aimé Bonny; G André Ng; Karen Sliwa; Andre Pascal Kengne; Ashley Chin; Ana Olga Mocumbi; Marcus Ngantcha; Olujimi A Ajijola; Gene Bukhman
Journal:  Glob Heart       Date:  2020-05-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.